Global Precision Medicine Partnering Terms and Agreements 2014-2021

Publisher Name :
Date: 01-May-2021
No. of pages: 750
Inquire Before Buying

The Global Precision Medicine Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the Precision Medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest Precision Medicine agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Precision Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Precision Medicine partnering deals.

The report presents financial deal term values for Precision Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Precision Medicine partnering field; both the leading deal values and most active Precision Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 1,200 online deal records of actual Precision Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Precision Medicine dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Precision Medicine dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Precision Medicine deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Precision Medicine dealmaking with a brief summary followed by a comprehensive listing of Precision Medicine deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Precision Medicine partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Precision Medicine partnering deals signed and announced since Jan 2014. The chapter is organized by specific Precision Medicine technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Precision Medicine partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Precision Medicine partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Precision Medicine technologies and products.

Key benefits

Global Precision Medicine Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:

In-depth understanding of Precision Medicine deal trends since 2014

Access to headline, upfront, milestone and royalty data

Detailed access to actual Precision Medicine contracts entered into by leading biopharma companies

Identify most active Precision Medicine dealmakers since 2014

Insight into terms included in a Precision Medicine partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Precision Medicine Partnering terms and Agreements 2014-2021 is intended to provide the reader with an in-depth understanding and access to Precision Medicine trends and structure of deals entered into by leading companies worldwide.

Precision Medicine Partnering Terms and Agreements includes:

Trends in Precision Medicine dealmaking in the biopharma industry since 2014

Analysis of Precision Medicine deal structure

Access to headline, upfront, milestone and royalty data

Access to Precision Medicine contract documents

Leading Precision Medicine deals by value since 2014

Most active Precision Medicine dealmakers since 2014

In Global Precision Medicine Partnering Terms and Agreements 2014-2021, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Precision Medicine Partnering Terms and Agreements 2014-2021 report provides comprehensive access to available deals and contract documents for over 1,200 Precision Medicine deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Precision Medicine Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:

In-depth understanding of Precision Medicine deal trends since 2014

Access to headline, upfront, milestone and royalty data

Detailed access to actual Precision Medicine contracts entered into by leading biopharma companies

Identify most active Precision Medicine dealmakers since 2014

Insight into terms included in a Precision Medicine partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Global Precision Medicine Partnering Terms and Agreements 2014-2021

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Precision Medicine dealmaking

2.1. Introduction
2.2. Precision Medicine partnering over the years
2.3. Most active Precision Medicine dealmakers
2.4. Precision Medicine partnering by deal type
2.5. Precision Medicine partnering by therapy area
2.6. Deal terms for Precision Medicine partnering
2.6.1 Precision Medicine partnering headline values
2.6.2 Precision Medicine deal upfront payments
2.6.3 Precision Medicine deal milestone payments
2.6.4 Precision Medicine royalty rates

Chapter 3 - Leading Precision Medicine deals

3.1. Introduction
3.2. Top Precision Medicine deals by value

Chapter 4 - Most active Precision Medicine dealmakers

4.1. Introduction
4.2. Most active Precision Medicine dealmakers
4.3. Most active Precision Medicine partnering company profiles

Chapter 5 - Precision Medicine contracts dealmaking directory

5.1. Introduction
5.2. Precision Medicine contracts dealmaking directory

Chapter 6 - Precision Medicine dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking


Appendices

Appendix 1 - Precision Medicine deals by company A-Z
Appendix 2 - Precision Medicine deals by stage of development
Appendix 3 - Precision Medicine deals by deal type
Appendix 4 - Precision Medicine deals by therapy area
Appendix 5 -Deal type definitions


About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Precision Medicine partnering since 2014
Figure 2: Active Precision Medicine dealmaking activity since 2014
Figure 3: Precision Medicine partnering by deal type since 2014
Figure 4: Precision Medicine partnering by disease type since 2014
Figure 5: Precision Medicine deals with a headline value
Figure 6: Precision Medicine deals with an upfront value
Figure 7: Precision Medicine deals with a milestone value
Figure 8: Precision Medicine deals with a royalty rate value
Figure 9: Top Precision Medicine deals by value since 2014
Figure 10: Most active Precision Medicine dealmakers since 2014
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
  • Global Dalbavancin Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 149
    The global Dalbavancin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dalbavancin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Intravenous Therapy - Oral Type Segmen......
  • Global Ceftaroline Fosamil Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 142
    The global Ceftaroline Fosamil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ceftaroline Fosamil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Injection Type - Oral Type ......
  • Global Thiamazole Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 139
    The global Thiamazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thiamazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablets - Ointment Segment by Applicatio......
  • Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 139
    The global Therapeutic Proteins for Cardiovascular Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Proteins for Cardiovascular Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.......
  • Global Tumor Nutrition Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 132
    The global Tumor Nutrition market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Nutrition market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Nutrition for Stomach Cancer - Nutrition for ......
  • Global Phenobarbital Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 133
    The global Phenobarbital market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phenobarbital market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Human use - For Livestock Segment ......
  • Global Rofecoxib Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 134
    The global Rofecoxib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rofecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Oral Suspension. - Tablet-Form Segment by ......
  • Global Atypical Antipsychotic Drugs Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 145
    The global Atypical Antipsychotic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atypical Antipsychotic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Risperidone - Olanz......
  • Global Nitroglycerin Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 139
    The global Nitroglycerin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nitroglycerin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablets - Onitments - Patches - Oth......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs